Confluence Wealth Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
Confluence Wealth Services's BMY Position: Q2 2026 in Review
Confluence Wealth Services increased its Bristol-Myers Squibb (BMY) stake by 45% in Q2 2026, buying an estimated $291K and bringing the position to 16,256 shares worth $937K. The position accounts for 0.03% of the portfolio, ranked #239.
Confluence Wealth Services first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.24M in Q2 2023. 1,158 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Confluence Wealth Services held 16,256 shares of Bristol-Myers Squibb worth $937K as of Q2 2026.
- Confluence Wealth Services bought 5,064 Bristol-Myers Squibb shares in Q2 2026, an estimated $291K.
- Bristol-Myers Squibb made up 0.03% of Confluence Wealth Services's portfolio in Q2 2026, its #239 holding.
- Confluence Wealth Services first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
- Confluence Wealth Services's Bristol-Myers Squibb position peaked at $1.24M in Q2 2023.
- 1,158 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Confluence Wealth Services's 13F filing for Q2 2026, filed 22 Jul 2026.